New research has shown that immunotherapy can be effective in treating prostate cancer in men who are selected based on the genetic characteristics of their tumors. In a recent study, it was found that for some men with a particular genetic type of prostate cancer, the progression of the disease was slowed down by 33 months.
source https://www.sciencedaily.com/releases/2024/09/240916115424.htm
The COVID‑19 pandemic exposed the load mothers carry—a burden that's still
being ignored today
-
The COVID-19 pandemic exacerbated and brought into focus the ongoing
disproportionate burden on mothers when it comes to household logistics,
child care an...
2 days ago
No comments:
Post a Comment